(FY)Jul 31, 2024 | (Q4)Jul 31, 2024 | (Q3)Apr 30, 2024 | (Q2)Jan 31, 2024 | (Q1)Oct 31, 2023 | (FY)Jul 31, 2023 | (Q4)Jul 31, 2023 | (Q3)Apr 30, 2023 | (Q2)Jan 31, 2023 | (Q1)Oct 31, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow (Indirect Method) | ||||||||||
Cash flow from continuing operating activities | -104.62%-256.31K | -29.06%594.9K | -1,492.98%-904.95K | -135.84%-905.21K | -54.73%958.95K | 6,802.55%5.55M | 112.11%838.57K | 124.26%64.97K | 1,974.23%2.53M | 737.97%2.12M |
Net income from continuing operations | -85.06%681.77K | -120.44%-279.83K | -90.84%109.82K | -91.13%114.9K | 5.22%736.87K | 650.67%4.56M | 184.20%1.37M | 873.54%1.2M | 372.84%1.3M | 358.50%700.31K |
Operating gains losses | -62.89%23.3K | 2.59%62.73K | -29.96%1.15K | ---11.93K | ---- | 15.06%62.78K | 443.85%61.14K | -91.08%1.64K | ---- | -96.10%1.39K |
Depreciation and amortization | 34.98%901.79K | 19.09%228.74K | 26.48%219.86K | 33.20%224.71K | 71.19%228.49K | 26.49%668.07K | 46.30%192.07K | 34.58%173.83K | 25.68%168.71K | -0.01%133.47K |
Asset impairment expenditure | 64.65%71.17K | -102.75%-331 | --0 | 39.39%43.1K | --28.4K | 86.78%43.22K | -3.72%12.05K | -97.57%258 | --30.92K | --0 |
Remuneration paid in stock | 179.99%142.76K | -65.70%11.22K | 3,556.54%21.79K | 1,567.15%43.8K | 338.46%65.95K | -6.40%50.99K | 24,320.15%32.72K | -95.51%596 | -81.07%2.63K | -44.65%15.04K |
Other non cashItems | -121.60%-15.68K | -875.47%-66.11K | -39.25%30.98K | 1,269.17%32.23K | -285.67%-33.85K | 655.12%72.6K | 120.83%8.53K | 39.15%51K | -107.56%-2.76K | 154.69%18.23K |
Change In working capital | -2,484.28%-2.06M | 176.27%638.49K | 5.33%-1.29M | -231.14%-1.35M | -105.35%-66.9K | 106.46%86.46K | -317.17%-837.09K | -127.21%-1.36M | 405.48%1.03M | 657.57%1.25M |
-Change in receivables | -214.94%-164.83K | -57.25%578.14K | 82.85%-267.02K | 355.30%44.31K | -242.29%-520.27K | 109.94%143.41K | 245.01%1.35M | -205.11%-1.56M | -106.93%-17.36K | 246.23%365.63K |
-Change in inventory | -18.41%-3.53M | 25.43%-1.5M | -138.94%-856.98K | -24.04%-1.17M | -100.73%-2.43K | -64.29%-2.98M | -713.29%-2.01M | -371.79%-358.66K | 19.37%-943.95K | 203.70%331.09K |
-Change in prepaid assets | 23.88%-137.1K | -36.44%-134.59K | 112.82%29.45K | -65.18%143.12K | 33.37%-175.09K | 34.53%-180.1K | 58.35%-98.64K | -531.53%-229.68K | 3,305.30%410.98K | -234.11%-262.77K |
-Change in payables and accrued expense | -43.02%1.77M | 21,995.57%1.69M | -127.38%-194.01K | -123.54%-368.57K | -22.69%630.89K | 41.46%3.1M | -99.37%7.66K | 1,174.88%708.58K | 162.80%1.57M | 92.54%816K |
-Change in other working capital | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --75.76K | --15.75K | ---- |
Cash from discontinued investing activities | ||||||||||
Operating cash flow | -104.62%-256.31K | -29.06%594.9K | -1,492.98%-904.95K | -135.84%-905.21K | -54.73%958.95K | 6,802.55%5.55M | 112.11%838.57K | 124.26%64.97K | 1,974.23%2.53M | 737.97%2.12M |
Investing cash flow | ||||||||||
Cash flow from continuing investing activities | 66.01%-328.33K | 82.39%-53.4K | 60.89%-132.41K | 58.47%-70.08K | 53.32%-72.44K | -360.42%-965.82K | -244.56%-303.32K | -1,130.45%-338.56K | -209.91%-168.74K | -290.21%-155.2K |
Net PPE purchase and sale | 66.01%-328.33K | 82.39%-53.4K | 60.89%-132.41K | 58.47%-70.08K | 53.32%-72.44K | -360.42%-965.82K | -244.56%-303.32K | -1,130.45%-338.56K | -209.91%-168.74K | -290.21%-155.2K |
Cash from discontinued investing activities | ||||||||||
Investing cash flow | 66.01%-328.33K | 82.39%-53.4K | 60.89%-132.41K | 58.47%-70.08K | 53.32%-72.44K | -360.42%-965.82K | -244.56%-303.32K | -1,130.45%-338.56K | -209.91%-168.74K | -290.21%-155.2K |
Financing cash flow | ||||||||||
Cash flow from continuing financing activities | 35.94%-962.03K | -159.08%-248.99K | 107.15%27.58K | 2.50%-355.34K | 41.21%-385.27K | -264.41%-1.5M | 56.32%-96.11K | -216.86%-385.78K | -466.81%-364.46K | -43.13%-655.36K |
Net issuance payments of debt | 47.58%-939.28K | 41.47%-221.72K | 107.56%24.73K | -11.34%-415.24K | 54.13%-327.05K | -404.44%-1.79M | -40.80%-378.82K | -196.07%-326.95K | -51.35%-372.94K | -296.02%-713.01K |
Net common stock issuance | -95.81%9K | --0 | --0 | --4K | --5K | 43.33%215K | --215K | --0 | --0 | --0 |
Cash dividends paid | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
Interest paid (cash flow from financing activities) | ---5.5K | --0 | --0 | ---998 | ---4.5K | --0 | --0 | --0 | --0 | --0 |
Net other financing activities | -134.99%-26.25K | -140.28%-27.27K | 104.85%2.85K | 571.44%56.89K | -201.85%-58.72K | 136.44%75K | 35.24%67.71K | -476.82%-58.83K | -73.60%8.47K | 120.75%57.65K |
Cash from discontinued financing activities | ||||||||||
Financing cash flow | 35.94%-962.03K | -159.08%-248.99K | 107.15%27.58K | 2.50%-355.34K | 41.21%-385.27K | -264.41%-1.5M | 56.32%-96.11K | -216.86%-385.78K | -466.81%-364.46K | -43.13%-655.36K |
Net cash flow | ||||||||||
Beginning cash position | 2,126.17%3.23M | -50.25%1.39M | -30.46%2.4M | 156.51%3.73M | 2,126.17%3.23M | -82.95%144.88K | 4,737.22%2.79M | 14,987.64%3.45M | 7,233.27%1.45M | -82.95%144.88K |
Current changes in cash | -150.21%-1.55M | -33.39%292.51K | -53.14%-1.01M | -166.78%-1.33M | -61.67%501.24K | 537.16%3.08M | 403.15%439.15K | -1,996.92%-659.37K | 65,752.35%1.99M | 257.63%1.31M |
End cash Position | -47.96%1.68M | -47.96%1.68M | -50.25%1.39M | -30.46%2.4M | 156.51%3.73M | 2,126.17%3.23M | 2,126.17%3.23M | 4,737.22%2.79M | 14,987.64%3.45M | 7,233.27%1.45M |
Free cash from | -113.02%-594.48K | 2.98%541.5K | -271.96%-1.04M | -141.79%-985.13K | -54.84%886.51K | 1,661.26%4.57M | 71.11%525.85K | 5.57%-278.89K | 3,401.06%2.36M | 627.99%1.96M |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
No Data